Athersys Inc

NASDAQ:ATHX  
0.24
-0.02 (-7.46%)
4:01:26 PM EDT: $0.25 +0.01 (+2.08%)
Debt Financing / Related, Layoffs, Officer Changes

Athersys Inc Announces Restructuring, Management Changes To Focus On Existing Clinical Programs

Published: 06/02/2022 20:16 GMT
Athersys Inc (ATHX) - Athersys Announces Restructuring and Management Changes to Focus on Its Existing Clinical Programs.
Athersys Inc - Reducing Its Workforce Up to 70%, With Majority of Reduction Expected to Be Completed by End of June 2022.
Athersys Inc - As Part of Restructuring Plan, Company Also Announced Changes to Its Executive Team.
Athersys Inc - William Lehmann, President and Chief Operating Officer, Left Company on May 31, 2022.
Athersys Inc - John Harrington, Executive Vice President, Chief Scientific Officer and Ivor Macleod, Cfo, Will Be Leaving Company on June 30, 2022.
Athersys - Even With Reduced Costs From Restructuring, Need to Raise Additional Capital to Reach Full Enrollment, Data Readout From Masters-2 Trial.
Athersys Inc - Will Continue to Partner With Healios Kk in Japan to Advance Ischemic Stroke and Acute Respiratory Distress Syndrome (ards) Programs.